This Is MS Multiple Sclerosis Community: Knowledge & Support

just want to show what health Canada is like .

Health Canada blocks dying patients from access to drug

Specialist 'appalled and angry' with federal agency

http://www.cbc.ca/news/canada/british-c ... enied.html

Delay Drugs One Year OR Reinforce your Healing WITH the Drugs by Optimizing your Nutrition and Treating the BLOOD REFLUX

On the site ThisisMs.com Alicia asked the following question:

Tues June 4 2013 General Discussion

"I have a question for you. How can anyone possibly tell if a disease modifying
drug is preventing relapses if no one really knows how MS works, everyone's MS
is different and it is impossible to predict when and how ...

http://www.xconomy.com/boston/2013/04/1 ... dsourcing/

This concept gives new hope to the thought that therapies that cannot be patented could still gain the statistically significant status needed to be accepted by the medical community.

There is a wealth of anecdotal data supporting things like:

Wheldon Protocol (ABX antibiotic regimens)
Procarin / histamine (Prokarin)
Low Dose Naltrexone (LDN)
PADMA-28
Protandin
Swank diet & supplement regimen

But these potentially life-altering therapies aren't even ...

Anyone else excited about this? Some results from the first clinical trial based on the nanoparticle research first published this last November.

http://www.sciencedaily.com/releases/20 ... 144312.htm

Quote:

"A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed the therapy was safe and dramatically reduced patients' immune systems' reactivity to myelin by 50 to 75 percent, according to new Northwestern Medicine ...

Hi
http://www.ehealthme.com/ds/tysabri/death
Regards
Rici

http://www.thecomedynetwork.ca/shows/Th ... age=134644

or
:rotflar; :-D
http://www.colbertnation.com/the-colber ... -marijuana

Contrary to recent “reports”, CCSVI isn’t “dead”. It is being
refined and rethought and is very much alive.

Dr. Zamboni’s groundbreaking insight poses two distinct problems.
First, the reflux of veinous blood into the central nervous system must be
halted (at best) or minimized. Second, the injured tissue must be healed.

Recent observations about cranial fluid dynamics, the possibility that cerebrospinal
fluid build-up can "pressure" venous blood circulation leading to a blood
reflux, implies that ...

A clinical trial now underway at Queen Mary University in London, England, called be INSPIRE trial (click here), is attempting to use Raltegravir to treat MS patients. Researchers hope that the drug will deactivate any activated retroviral material in the DNA of MS patients, while perhaps also combating EBV, and thus stop multiple sclerosis in its tracks. Another group of researchers in Switzerland are trying to accomplish the same outcome using an experimental drug that ...

Very early stages, but I did not see any reference to it on TIMS.

http://m.pnas.org/content/early/2013/02/06/1300313110.short

Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis
A therapeutic goal in the treatment of certain CNS diseases, including multiple sclerosis, amyotrophic lateral sclerosis, and Parkinson disease, is to down-regulate inflammatory pathways. Inflammatory molecules produced by microglia are responsible for removal of damaged neurons, but can cause collateral damage to normal neurons located close ...

I have just started Tecfidera after four years on Avonex. The side effects of Avonex never let up. I'd love to get in touch with anyone else who is taking Tecfidera. So far, I'm doing very well--but I'm still on half doses. Next week I start full doses.